Plasma Betatrophin Levels in Non-alcoholic Fatty Liver Disease

The study searched for answers to two questions:

1-What are the plasma betatrophin levels in subjects with non-alcoholic fatty liver disease and healthy controls.

2. Is there any relationship between plasma betatropin levels and different stage of non-alcoholic fatty liver disease 2.Is there any relationship between plasma betatropin levels and metabolic parameters in subjects with non-alcoholic fatty liver disease.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Non-Alcoholic Fatty Liver Disease Digestive System Diseases Fatty Liver Liver Diseases

Age range

20 year–40 year

Sex eligibility

Male

Study type

Observational

Primary location

Gulhane School of Medicine Department of Endocrinology and Metabolism

Ankara, 06018, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with biopsy proven non-alcoholic fatty liver disease

Exclusion criteria

Taking any drugs
>20 gr/day alcohol consumption
chronic metabolic diseases
morbid obesity

Treatment and study plan

Primary outcomes

Plasma betatrophin levels in subjects with non-alcoholic fatty liver disease and healthy controls.

Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Gulhane School of Medicine

Other

Registry information

Official study title

The Cross Sectional Study to Investigate the Plasma Betatrophin Levels in Non-alcoholic Fatty Liver Disease and Healthy Controls

Important dates

Study start: 2009
Primary completion: 2013
Study completion: 2014
First posted: Jun 27, 2014
Registry last updated: Jun 27, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed